Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective.
Front Oncol. 2022 Feb 4;12:780716. doi: 10.3389/fonc.2022.780716. eCollection 2022.
Front Oncol. 2022.
PMID: 35186729
Free PMC article.
Review.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Zaniboni A, Barone CA, Banzi MC, Bergamo F, Blasi L, Bordonaro R, Bartolomeo MD, Costanzo FD, Frassineti GL, Garufi C, Giuliani F, Latiano TP, Martinelli E, Personeni N, Racca P, Tamburini E, Tonini G, Besse MG, Spione M, Falcone A.
Zaniboni A, et al. Among authors: bartolomeo md.
Future Oncol. 2021 Jun;17(18):2315-2324. doi: 10.2217/fon-2020-1278. Epub 2021 Mar 5.
Future Oncol. 2021.
PMID: 33663264
Clinical Trial.
Item in Clipboard
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancer.
Barone C, Bartolomeo MD, Lonardi S, Maiello E, Martinelli E, Moretto R, Strippoli A, Tamburini E, Zaniboni A, Pinto C.
Barone C, et al. Among authors: bartolomeo md.
Future Oncol. 2021 May;17(14):1749-1759. doi: 10.2217/fon-2020-1181. Epub 2021 Jan 19.
Future Oncol. 2021.
PMID: 33464133
Free article.
Item in Clipboard
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis.
Cremolini C, Antoniotti C, Pietrantonio F, Berenato R, Tampellini M, Baratelli C, Salvatore L, Marmorino F, Borelli B, Nichetti F, Bironzo P, Sonetto C, Bartolomeo MD, Braud F, Loupakis F, Falcone A, Di Maio M.
Cremolini C, et al. Among authors: bartolomeo md.
Cancer Res Treat. 2017 Jul;49(3):834-845. doi: 10.4143/crt.2016.249. Epub 2016 Nov 15.
Cancer Res Treat. 2017.
PMID: 27857020
Free PMC article.
Review.
Item in Clipboard
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer.
Hill AG, Findlay MP, Burge ME, Jackson C, Alfonso PG, Samuel L, Ganju V, Karthaus M, Amatu A, Jeffery M, Bartolomeo MD, Bridgewater J, Coveler AL, Hidalgo M, Kapp AV, Sufan RI, McCall BB, Hanley WD, Penuel EM, Pirzkall A, Tabernero J.
Hill AG, et al. Among authors: bartolomeo md.
Clin Cancer Res. 2018 May 15;24(10):2276-2284. doi: 10.1158/1078-0432.CCR-17-0646. Epub 2018 Mar 5.
Clin Cancer Res. 2018.
PMID: 29506988
Clinical Trial.
Item in Clipboard
Corrigendum to 'Hypotonic Infant with PURA Syndrome-related Channelopathy Successfully Treated with Pyridostigmine' Neuromuscular Disorders Volume 32, Issue 2, February 2022, Pages 166-169.
Wyrebek R, Bartolomeo MD, Brooks S, Geller T, Crenshaw M, Iyadurai S.
Wyrebek R, et al. Among authors: bartolomeo md.
Neuromuscul Disord. 2022 Aug;32(8):e1. doi: 10.1016/j.nmd.2022.06.008. Epub 2022 Jul 21.
Neuromuscul Disord. 2022.
PMID: 35871129
No abstract available.
Item in Clipboard
Cite
Cite